Kater L - Search Results

1

Laboratory tests as predictors of flares in systemic lupus erythematosus: comment on the article by Esdaile et al.

Kallenberg CG, Bootsma H, Spronk PE, ter Borg EJ, Derksen RH, Kater L. Kallenberg CG, et al. Among authors: kater l. Arthritis Rheum. 1997 Feb;40(2):393-4. doi: 10.1002/art.1780400231. Arthritis Rheum. 1997. PMID: 9041957 No abstract available.

2

Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients.

Duits AJ, Bootsma H, Derksen RH, Spronk PE, Kater L, Kallenberg CG, Capel PJ, Westerdaal NA, Spierenburg GT, Gmelig-Meyling FH, et al. Duits AJ, et al. Among authors: kater l. Arthritis Rheum. 1995 Dec;38(12):1832-6. doi: 10.1002/art.1780381217. Arthritis Rheum. 1995. PMID: 8849356

3

Chorea in systemic lupus erythematosus and "lupus-like" disease: association with antiphospholipid antibodies.

Asherson RA, Derksen RH, Harris EN, Bouma BN, Gharavi AE, Kater L, Hughes GR. Asherson RA, et al. Among authors: kater l. Semin Arthritis Rheum. 1987 May;16(4):253-9. doi: 10.1016/0049-0172(87)90003-5. Semin Arthritis Rheum. 1987. PMID: 3110955

4

Discordant effects of prednisone on anticardiolipin antibodies and the lupus anticoagulant.

Derksen RH, Biesma D, Bouma BN, Gmelig Meyling FH, Kater L. Derksen RH, et al. Among authors: kater l. Arthritis Rheum. 1986 Oct;29(10):1295-6. doi: 10.1002/art.1780291021. Arthritis Rheum. 1986. PMID: 3094545 No abstract available.

5

The striking association between lupus anticoagulant and fetal loss in systemic lupus erythematosus patients.

Derksen RH, Bouma BN, Kater L. Derksen RH, et al. Among authors: kater l. Arthritis Rheum. 1986 May;29(5):695-6. doi: 10.1002/art.1780290520. Arthritis Rheum. 1986. PMID: 3087369 No abstract available.

6

Pregnancy in systemic lupus erythematosus: a prospective study.

Derksen RH, Bruinse HW, de Groot PG, Kater L. Derksen RH, et al. Among authors: kater l. Lupus. 1994 Jun;3(3):149-55. doi: 10.1177/096120339400300304. Lupus. 1994. PMID: 7951299

7

Prevention of relapses in systemic lupus erythematosus.

Bootsma H, Spronk P, Derksen R, de Boer G, Wolters-Dicke H, Hermans J, Limburg P, Gmelig-Meyling F, Kater L, Kallenberg C. Bootsma H, et al. Among authors: kater l. Lancet. 1995 Jun 24;345(8965):1595-9. doi: 10.1016/s0140-6736(95)90114-0. Lancet. 1995. PMID: 7783536 Clinical Trial.

8

Treatment of systemic lupus erythematosus: which options do we have for therapy regimens?

Kater L, Derksen RH, Hené RJ. Kater L, et al. Rheumatol Int. 1991;11(3):137-40. doi: 10.1007/BF00304503. Rheumatol Int. 1991. PMID: 1754817 Review.

9

Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus.

Coremans IE, Spronk PE, Bootsma H, Daha MR, van der Voort EA, Kater L, Breedveld FC, Kallenberg CG. Coremans IE, et al. Among authors: kater l. Am J Kidney Dis. 1995 Oct;26(4):595-601. doi: 10.1016/0272-6386(95)90595-2. Am J Kidney Dis. 1995. PMID: 7573013

10

The prevalence and clinical associations of the lupus anticoagulant in systemic lupus erythematosus.

Derksen RH, Bouma BN, Kater L. Derksen RH, et al. Among authors: kater l. Scand J Rheumatol. 1987;16(3):185-92. doi: 10.3109/03009748709165272. Scand J Rheumatol. 1987. PMID: 3110945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results